<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To investigate the relationships between serum concentrations of soluble <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules and <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, or other conventional risk factors in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, we measured soluble intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 (sICAM-1), vascular cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1 (sVCAM-1), E-selectin (sE-selectin), insulin sensitivity, and conventional risk factors in 150 Japanese type 2 diabetic patients without apparent <z:e sem="disease" ids="C1504375" disease_type="Disease or Syndrome" abbrv="">diabetic macroangiopathy</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>High serum concentrations of sVCAM-1 and sE-selectin were observed in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Serum concentrations of soluble <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules were not significantly influenced by sex, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, or <z:e sem="disease" ids="C0155765" disease_type="Disease or Syndrome" abbrv="">microangiopathy</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Spearman correlation showed that sVCAM-1 concentrations correlated significantly with fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> (FPG), fasting C-<z:chebi fb="7" ids="16670">peptide</z:chebi>, and insulin sensitivity [K index of the insulin tolerance test (K(ITT))] (rho=0.19,0.23, and -0.23, respectively) </plain></SENT>
<SENT sid="4" pm="."><plain>Soluble E-selectin concentrations correlated significantly with body mass index (BMI), FPG, fasting C-<z:chebi fb="7" ids="16670">peptide</z:chebi>, insulin sensitivity, and <z:chebi fb="0" ids="17855">triglyceride</z:chebi> (rho=0.33,0.42,0.26,-0.48, and 0.29, respectively) </plain></SENT>
<SENT sid="5" pm="."><plain>Multiple regression analysis showed that FPG, fasting C-<z:chebi fb="7" ids="16670">peptide</z:chebi>, and total cholesterol were independent factors that correlated with sVCAM-1 levels </plain></SENT>
<SENT sid="6" pm="."><plain>BMI, FPG, and insulin sensitivity were independent factors that correlated with sE-selectin levels </plain></SENT>
<SENT sid="7" pm="."><plain>Serum concentrations of sE-selectin significantly increased associated with clustering of conventional risk factors those <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, and current smoking (P&lt;0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, sVCAM-1 and sE-selectin levels are related to both <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Soluble E-selectin levels may be related to <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and may reflect the presence of a multiple risk factor clustering syndrome </plain></SENT>
</text></document>